Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke

Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence h...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 39; no. 4; pp. 743 - 757
Main Authors Sladojevic, Nikola, Stamatovic, Svetlana M., Johnson, Allison M., Choi, Jennifer, Hu, Anna, Dithmer, Sophie, Blasig, Ingolf E., Keep, Richard F., Andjelkovic, Anuska V.
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 23.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB “leakage“ found subacutely or chronically. The current study examined BBB structural alterations during the “BBB leakage” associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis - and trans -interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis - and trans -interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential “defect” in postischemic barrier formation that may underlie prolonged vessel leakiness. SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood–brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke.
AbstractList Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic - and -interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 - and -interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential "defect" in postischemic barrier formation that may underlie prolonged vessel leakiness. Although rarely expressed at the normal blood-brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke.
Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis- and trans-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis- and trans-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential "defect" in postischemic barrier formation that may underlie prolonged vessel leakiness.SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood-brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke.Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis- and trans-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis- and trans-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential "defect" in postischemic barrier formation that may underlie prolonged vessel leakiness.SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood-brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke.
Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB “leakage“ found subacutely or chronically. The current study examined BBB structural alterations during the “BBB leakage” associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis - and trans -interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis - and trans -interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential “defect” in postischemic barrier formation that may underlie prolonged vessel leakiness. SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood–brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke.
Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB “leakage“ found subacutely or chronically. The current study examined BBB structural alterations during the “BBB leakage” associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis- and trans-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis- and trans-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential “defect” in postischemic barrier formation that may underlie prolonged vessel leakiness.
Author Choi, Jennifer
Hu, Anna
Andjelkovic, Anuska V.
Johnson, Allison M.
Keep, Richard F.
Sladojevic, Nikola
Blasig, Ingolf E.
Stamatovic, Svetlana M.
Dithmer, Sophie
Author_xml – sequence: 1
  givenname: Nikola
  surname: Sladojevic
  fullname: Sladojevic, Nikola
– sequence: 2
  givenname: Svetlana M.
  surname: Stamatovic
  fullname: Stamatovic, Svetlana M.
– sequence: 3
  givenname: Allison M.
  surname: Johnson
  fullname: Johnson, Allison M.
– sequence: 4
  givenname: Jennifer
  surname: Choi
  fullname: Choi, Jennifer
– sequence: 5
  givenname: Anna
  surname: Hu
  fullname: Hu, Anna
– sequence: 6
  givenname: Sophie
  surname: Dithmer
  fullname: Dithmer, Sophie
– sequence: 7
  givenname: Ingolf E.
  surname: Blasig
  fullname: Blasig, Ingolf E.
– sequence: 8
  givenname: Richard F.
  orcidid: 0000-0001-6441-5334
  surname: Keep
  fullname: Keep, Richard F.
– sequence: 9
  givenname: Anuska V.
  orcidid: 0000-0001-8365-8016
  surname: Andjelkovic
  fullname: Andjelkovic, Anuska V.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30504279$$D View this record in MEDLINE/PubMed
BookMark eNqFkd1O3DAQha2Kqiy0r4AiccNNFv87kRASm6UtFQIJyrVl4knXkLUXJ6lUrniHvmGfBKf8CLjhyiPNN8dn5mygNR88ILRF8JQIynZ_nBxenJ2eV0dTwhnNSTGlmBQf0CR1y5xyTNbQBFOFc8kVX0cbXXeFMVaYqE9onWGBOVXlBJ1VrRms8znJ57ACb8H32Ry63ly61t2a3gWfhSbrF5DN2hDsv7u_s2icz2YmRgcxS2W1iMG7OjvvY7iGz-hjY9oOvjy-m-ji6-HP6nt-fPrtqDo4zmuBiz5XDbVYcAFFKRrVcAoKhCgtZQxUUytlC0KASMpko0RtLDdWUlGWVElujWSbaP9BdzVcLsHWyXk0rV5FtzTxjw7G6dcd7xb6V_itJeNM8lFg51Eghpsh7ayXrquhbY2HMHSaEl5iwpjiCd1-g16FIfq0XqIUTRAVo-DWS0fPVp7OnYC9B6COoesiNLp2_f8bJ4Ou1QTrMV39nK4e09Wk0GO6aVy-GX_64Z3BexPDqe8
CitedBy_id crossref_primary_10_1016_j_biopha_2023_115272
crossref_primary_10_1080_21688370_2025_2470482
crossref_primary_10_3389_fneur_2020_594672
crossref_primary_10_47093_2218_7332_2021_12_4_39_50
crossref_primary_10_1016_j_jss_2024_06_007
crossref_primary_10_14336_AD_2022_0212
crossref_primary_10_3390_ijms21020569
crossref_primary_10_3390_ijms24129784
crossref_primary_10_6061_clinics_2021_e2167
crossref_primary_10_1038_s41385_022_00550_7
crossref_primary_10_3390_ijms22041512
crossref_primary_10_1016_j_mvr_2020_104059
crossref_primary_10_1007_s11046_022_00653_6
crossref_primary_10_1186_s12987_020_00192_6
crossref_primary_10_1515_revneuro_2020_0067
crossref_primary_10_1007_s10571_023_01437_2
crossref_primary_10_1016_j_bbi_2023_07_009
crossref_primary_10_3390_ijms20215372
crossref_primary_10_1007_s12035_024_03939_6
crossref_primary_10_1016_j_addr_2023_114820
crossref_primary_10_2174_1570159X18666200720173316
crossref_primary_10_1186_s12987_024_00563_3
crossref_primary_10_1007_s12035_023_03655_7
crossref_primary_10_1186_s12987_020_00181_9
crossref_primary_10_1172_jci_insight_168475
crossref_primary_10_3390_ijms25053065
crossref_primary_10_1139_bcb_2023_0047
crossref_primary_10_1016_j_biomaterials_2025_123138
crossref_primary_10_1016_j_brainresbull_2022_09_017
crossref_primary_10_1016_j_drudis_2020_05_007
crossref_primary_10_1186_s12987_022_00371_7
crossref_primary_10_1016_j_bbamem_2020_183298
crossref_primary_10_1186_s12974_020_01946_7
crossref_primary_10_1038_s41598_023_49861_0
crossref_primary_10_3389_fphar_2021_748568
crossref_primary_10_1016_j_atherosclerosis_2025_119149
crossref_primary_10_1016_j_jep_2023_117700
crossref_primary_10_1038_s41420_021_00773_w
crossref_primary_10_1016_j_nbd_2023_106277
crossref_primary_10_3389_fncel_2022_931247
crossref_primary_10_1007_s00221_025_07018_7
crossref_primary_10_1016_j_immuni_2024_12_008
crossref_primary_10_1111_cns_13561
crossref_primary_10_1186_s12987_022_00386_0
crossref_primary_10_3390_ijms241512034
crossref_primary_10_1007_s12033_023_00835_7
crossref_primary_10_3390_cells10112997
crossref_primary_10_1016_j_intimp_2023_109850
crossref_primary_10_1039_D4SD00063C
crossref_primary_10_1007_s10456_021_09796_4
crossref_primary_10_3389_fddev_2022_1027098
crossref_primary_10_3390_jcm14020386
crossref_primary_10_1186_s12986_022_00675_3
crossref_primary_10_1007_s12035_022_02761_2
crossref_primary_10_1017_S1431927620020942
crossref_primary_10_3390_ijms241612689
crossref_primary_10_1021_acsnano_1c08432
crossref_primary_10_1080_1028415X_2021_1889452
crossref_primary_10_1186_s12987_019_0124_y
crossref_primary_10_3390_ijms232112781
crossref_primary_10_1016_j_bbi_2021_05_011
crossref_primary_10_3389_fcimb_2021_647048
crossref_primary_10_1177_15357597221127164
crossref_primary_10_3389_fimmu_2022_796288
crossref_primary_10_1007_s11011_021_00694_8
crossref_primary_10_17816_onco636917
crossref_primary_10_1186_s12987_020_00202_7
crossref_primary_10_25692_ACEN_2021_2_1
crossref_primary_10_1097_WNR_0000000000002098
crossref_primary_10_3389_fnmol_2021_752781
crossref_primary_10_1016_j_jneuroim_2021_577763
crossref_primary_10_3390_biomedicines10081792
crossref_primary_10_2745_dds_34_374
crossref_primary_10_1248_bpb_b21_00408
crossref_primary_10_1016_j_pharmthera_2023_108541
crossref_primary_10_1038_s41419_019_1771_2
crossref_primary_10_1186_s12974_023_02908_5
crossref_primary_10_3390_pharmaceutics13111980
crossref_primary_10_1016_j_prp_2023_155085
crossref_primary_10_1161_ATVBAHA_119_312816
crossref_primary_10_3390_ohbm5020016
crossref_primary_10_1080_21688370_2021_1926190
crossref_primary_10_3389_fncel_2020_540669
crossref_primary_10_1186_s12987_020_00179_3
crossref_primary_10_1039_D1FO00155H
crossref_primary_10_1007_s12035_021_02654_w
crossref_primary_10_3390_nu14091698
crossref_primary_10_1016_j_jmb_2020_02_034
crossref_primary_10_1177_0271678X241299960
crossref_primary_10_3390_ijms23147813
crossref_primary_10_1038_s41598_025_93756_1
crossref_primary_10_1186_s12987_023_00414_7
crossref_primary_10_3390_cells10040963
Cites_doi 10.1083/jcb.201412147
10.1159/000336116
10.1016/j.biomaterials.2015.03.007
10.1007/BF02634568
10.1186/s12979-015-0029-9
10.1016/j.expneurol.2009.06.002
10.1523/JNEUROSCI.5977-11.2012
10.1038/nm.3363
10.1016/j.nbd.2009.07.030
10.1002/jcp.20823
10.1523/JNEUROSCI.20-23-j0004.2000
10.1016/S0028-3908(00)00003-4
10.1096/fj.13-248880
10.1016/j.neulet.2008.08.082
10.1161/STROKEAHA.110.608257
10.1083/jcb.147.4.891
10.1038/jcbfm.2011.79
10.1080/21688370.2016.1154641
10.1161/STROKEAHA.110.611731
10.1186/s12974-017-0933-3
10.1172/JCI91301
10.1016/j.nbd.2014.03.010
10.1038/sj.jcbfm.9600229
10.1161/01.STR.0000250235.80253.e9
10.1096/fj.07-8319com
10.2174/092986708783330665
10.1016/S0166-2236(99)01401-0
10.1038/jcbfm.2014.199
10.1016/0361-9230(80)90166-5
10.1042/BJ20150148
10.1083/jcb.200302070
10.1038/ncomms12276
10.1007/s004010000180
10.1001/archinte.160.21.3196
10.1124/pr.57.2.4
10.1007/s00401-011-0883-2
10.1016/j.brainres.2009.05.025
10.1146/annurev-physiol-030212-183809
10.1042/BJ20140431
10.1016/j.neuroscience.2008.02.012
ContentType Journal Article
Copyright Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0.
Copyright Society for Neuroscience Jan 23, 2019
Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0 2019
Copyright_xml – notice: Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0.
– notice: Copyright Society for Neuroscience Jan 23, 2019
– notice: Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
DOI 10.1523/JNEUROSCI.1432-18.2018
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
Animal Behavior Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef

Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 757
ExternalDocumentID PMC6343646
30504279
10_1523_JNEUROSCI_1432_18_2018
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: RF1 AG057928
– fundername: NINDS NIH HHS
  grantid: R21 NS098211
– fundername: NINDS NIH HHS
  grantid: R01 NS062853
– fundername: NINDS NIH HHS
  grantid: R21 NS098066
– fundername: NINDS NIH HHS
  grantid: R56 NS062853
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
AAFWJ
AAJMC
AAYXX
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
ADHGD
AENEX
AFCFT
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
OK1
P0W
P2P
QZG
R.V
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
YBU
YHG
YKV
YNH
YSK
AFHIN
AIZTS
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7QG
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
ID FETCH-LOGICAL-c508t-7f2d0545e895f7f42e7e559d233e7fc77d811e16236f75cad4ad625992764da63
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 13:52:28 EDT 2025
Fri Jul 11 05:48:36 EDT 2025
Mon Jun 30 16:40:56 EDT 2025
Wed Feb 19 02:30:39 EST 2025
Tue Jul 01 04:15:40 EDT 2025
Thu Apr 24 23:03:31 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords cerebrovascular injury
claudin-1
BBB recovery
stroke
Language English
License https://creativecommons.org/licenses/by-nc-sa/4.0
Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c508t-7f2d0545e895f7f42e7e559d233e7fc77d811e16236f75cad4ad625992764da63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
N. Sladojevic's present address: Department of Medicine, Section of Cardiology, University of Chicago, Chicago IL, 60637.
Author contributions: N.S., S.M.S., I.E.B., and R.F.K. edited the paper; A.V.A. wrote the first draft of the paper. R.F.K. and A.V.A. designed research; N.S., S.M.S., A.M.J., J.C., A.H., and A.V.A. performed research; S.D. and I.E.B. contributed unpublished reagents/analytic tools; N.S., S.M.S., A.M.J., J.C., A.H., and A.V.A. analyzed data; N.S., R.F.K., and A.V.A. wrote the paper.
ORCID 0000-0001-6441-5334
0000-0001-8365-8016
OpenAccessLink https://www.jneurosci.org/content/jneuro/39/4/743.full.pdf
PMID 30504279
PQID 2172133256
PQPubID 2049535
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6343646
proquest_miscellaneous_2149013374
proquest_journals_2172133256
pubmed_primary_30504279
crossref_citationtrail_10_1523_JNEUROSCI_1432_18_2018
crossref_primary_10_1523_JNEUROSCI_1432_18_2018
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-01-23
PublicationDateYYYYMMDD 2019-01-23
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-23
  day: 23
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Baltimore
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2019
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References 2023041803343637000_39.4.743.1
2023041803343637000_39.4.743.15
2023041803343637000_39.4.743.37
2023041803343637000_39.4.743.16
2023041803343637000_39.4.743.38
2023041803343637000_39.4.743.13
2023041803343637000_39.4.743.35
2023041803343637000_39.4.743.14
2023041803343637000_39.4.743.36
2023041803343637000_39.4.743.5
2023041803343637000_39.4.743.19
2023041803343637000_39.4.743.4
2023041803343637000_39.4.743.3
2023041803343637000_39.4.743.17
2023041803343637000_39.4.743.39
2023041803343637000_39.4.743.2
2023041803343637000_39.4.743.18
2023041803343637000_39.4.743.30
2023041803343637000_39.4.743.11
2023041803343637000_39.4.743.33
2023041803343637000_39.4.743.12
2023041803343637000_39.4.743.34
2023041803343637000_39.4.743.31
2023041803343637000_39.4.743.10
2023041803343637000_39.4.743.32
2023041803343637000_39.4.743.9
2023041803343637000_39.4.743.8
2023041803343637000_39.4.743.7
2023041803343637000_39.4.743.6
2023041803343637000_39.4.743.26
2023041803343637000_39.4.743.27
2023041803343637000_39.4.743.24
2023041803343637000_39.4.743.25
2023041803343637000_39.4.743.28
2023041803343637000_39.4.743.29
2023041803343637000_39.4.743.40
2023041803343637000_39.4.743.22
2023041803343637000_39.4.743.23
2023041803343637000_39.4.743.20
2023041803343637000_39.4.743.21
References_xml – ident: 2023041803343637000_39.4.743.37
  doi: 10.1083/jcb.201412147
– ident: 2023041803343637000_39.4.743.4
  doi: 10.1159/000336116
– ident: 2023041803343637000_39.4.743.33
  doi: 10.1016/j.biomaterials.2015.03.007
– ident: 2023041803343637000_39.4.743.18
  doi: 10.1007/BF02634568
– ident: 2023041803343637000_39.4.743.10
  doi: 10.1186/s12979-015-0029-9
– ident: 2023041803343637000_39.4.743.2
  doi: 10.1016/j.expneurol.2009.06.002
– ident: 2023041803343637000_39.4.743.11
  doi: 10.1523/JNEUROSCI.5977-11.2012
– ident: 2023041803343637000_39.4.743.14
  doi: 10.1038/nm.3363
– ident: 2023041803343637000_39.4.743.1
  doi: 10.1016/j.nbd.2009.07.030
– ident: 2023041803343637000_39.4.743.26
  doi: 10.1002/jcp.20823
– ident: 2023041803343637000_39.4.743.7
  doi: 10.1523/JNEUROSCI.20-23-j0004.2000
– ident: 2023041803343637000_39.4.743.8
  doi: 10.1016/S0028-3908(00)00003-4
– ident: 2023041803343637000_39.4.743.22
  doi: 10.1096/fj.13-248880
– ident: 2023041803343637000_39.4.743.31
  doi: 10.1016/j.neulet.2008.08.082
– ident: 2023041803343637000_39.4.743.40
  doi: 10.1161/STROKEAHA.110.608257
– ident: 2023041803343637000_39.4.743.13
  doi: 10.1083/jcb.147.4.891
– ident: 2023041803343637000_39.4.743.17
  doi: 10.1038/jcbfm.2011.79
– ident: 2023041803343637000_39.4.743.34
  doi: 10.1080/21688370.2016.1154641
– ident: 2023041803343637000_39.4.743.36
  doi: 10.1161/STROKEAHA.110.611731
– ident: 2023041803343637000_39.4.743.38
  doi: 10.1186/s12974-017-0933-3
– ident: 2023041803343637000_39.4.743.16
  doi: 10.1172/JCI91301
– ident: 2023041803343637000_39.4.743.32
  doi: 10.1016/j.nbd.2014.03.010
– ident: 2023041803343637000_39.4.743.5
  doi: 10.1038/sj.jcbfm.9600229
– ident: 2023041803343637000_39.4.743.3
  doi: 10.1161/01.STR.0000250235.80253.e9
– ident: 2023041803343637000_39.4.743.28
  doi: 10.1096/fj.07-8319com
– ident: 2023041803343637000_39.4.743.39
  doi: 10.2174/092986708783330665
– ident: 2023041803343637000_39.4.743.6
  doi: 10.1016/S0166-2236(99)01401-0
– ident: 2023041803343637000_39.4.743.20
  doi: 10.1038/jcbfm.2014.199
– ident: 2023041803343637000_39.4.743.25
  doi: 10.1016/0361-9230(80)90166-5
– ident: 2023041803343637000_39.4.743.23
  doi: 10.1042/BJ20150148
– ident: 2023041803343637000_39.4.743.24
  doi: 10.1083/jcb.200302070
– ident: 2023041803343637000_39.4.743.30
  doi: 10.1038/ncomms12276
– ident: 2023041803343637000_39.4.743.21
  doi: 10.1007/s004010000180
– ident: 2023041803343637000_39.4.743.12
  doi: 10.1001/archinte.160.21.3196
– ident: 2023041803343637000_39.4.743.15
  doi: 10.1124/pr.57.2.4
– ident: 2023041803343637000_39.4.743.27
  doi: 10.1007/s00401-011-0883-2
– ident: 2023041803343637000_39.4.743.9
  doi: 10.1016/j.brainres.2009.05.025
– ident: 2023041803343637000_39.4.743.19
  doi: 10.1146/annurev-physiol-030212-183809
– ident: 2023041803343637000_39.4.743.29
  doi: 10.1042/BJ20140431
– ident: 2023041803343637000_39.4.743.35
  doi: 10.1016/j.neuroscience.2008.02.012
SSID ssj0007017
Score 2.5702672
Snippet Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence...
Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 743
SubjectTerms Animals
Barriers
Blood vessels
Blood-brain barrier
Blood-Brain Barrier - pathology
Brain
Brain Ischemia - pathology
Cell membranes
Claudin-1 - genetics
Claudin-5 - biosynthesis
Claudin-5 - genetics
Dementia disorders
Destabilization
Down-Regulation - genetics
Endothelial cells
Endothelial Cells - pathology
Energy recovery
Energy transfer
Female
Fluorescence
Fluorescence recovery after photobleaching
Fluorescence resonance energy transfer
Health risks
Humans
Infarction, Middle Cerebral Artery - genetics
Infarction, Middle Cerebral Artery - pathology
Inflammation
Inflammation - pathology
Leakage
Male
Mice
Morphology
mRNA
Permeability
Phenotypes
Photobleaching
Proteins
Recovery of function
Stroke
Stroke - genetics
Stroke - pathology
Substrates
Tight Junctions - pathology
Vascular dementia
Zonula occludens-1 protein
Zonula Occludens-1 Protein - biosynthesis
Zonula Occludens-1 Protein - genetics
Title Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke
URI https://www.ncbi.nlm.nih.gov/pubmed/30504279
https://www.proquest.com/docview/2172133256
https://www.proquest.com/docview/2149013374
https://pubmed.ncbi.nlm.nih.gov/PMC6343646
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgvPCCgHEJDBQkxAsKW2wnTh5Ht2kboyC1lfpmObYjxkKCIEViv57jS910q8TgJYrspK58vhx_xz4XhF5ne6JQkpCEKl0lVJZVItIKJzQTuk6xEtjm6f44zo9n9HSezVcb-ja6pK_eycuNcSX_I1VoA7maKNl_kGz4UWiAe5AvXEHCcL2RjEeNWMDaA_bZga9l2781hqTNmnsZyKD1AbAO6u9NQQhzxmDr1JmAP5cb1xxOdxdrXkGrmDHLVgd5LwMUJo1Q3VdYWaXD1EXXBCUPJBa4cOf7Jr9034hWrPZefWUuF2PT2DqIA1eD7nzoeTPcmTDBUGnigoeXyhTb0xuHHb2hzWtgl87II40O1ClzKZyuqfnMpps4HRtvx8noBNQ9wUlqPfWK1cK2PMwff-JHs7MzPj2cT2-jOxgMClPr4uDkQ1iz2Z6tzRz-nY8lh3F2N4-yTmOu2SZXXWwHnGV6H93z4ov3HXIeoFu6fYi291sQzLff8ZvYuv_ac5Vt9HkDmOIrYIq7OgYwxQMwxR5MMdx6MMUOTI_Q7OhwOjpOfLmNRAJL7xNWYwUEPtNFmdWsplgzDfamwoRoVkvGVJGmOgW-nNcsk0JRoYz1XGKWUyVy8hhttV2rnxp_uRx4fp2VssC0kFVVKVyoUpNcSphiEqFsOXtc-lz0piRKw41NCrPOw6xzM-s8LbiZ9Qjthve-u2wsf31jZykc7r_cn9wUZUsJAbYfoVehG_SqOSwTre4W5hkKVJkQRiP0xMkyDAlrpClRU0aIrUk5PGBytq_3tOdfbO72nFCS0_zZDcZ9ju6uvqodtNX_WOgXwID76qUF7x8g6bAG
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Claudin-1-Dependent+Destabilization+of+the+Blood-Brain+Barrier+in+Chronic+Stroke&rft.jtitle=The+Journal+of+neuroscience&rft.au=Sladojevic%2C+Nikola&rft.au=Stamatovic%2C+Svetlana+M&rft.au=Johnson%2C+Allison+M&rft.au=Choi%2C+Jennifer&rft.date=2019-01-23&rft.issn=1529-2401&rft.eissn=1529-2401&rft.volume=39&rft.issue=4&rft.spage=743&rft_id=info:doi/10.1523%2FJNEUROSCI.1432-18.2018&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon